Paper354483
Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
Chandra B. Ann Neurol, 1978. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Papers, record 354483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/354483
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Intracranial Aneurysm | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Tranexamic Acid | Major topic |
| Adult | |
| Aged | |
| Aminocaproic Acid | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Rupture, Spontaneous |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42095754 | European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42095754 | PubMed |
| 40599738 | Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis. | Front Neurol | 2025 | https://conductscience.org/library/papers/40599738 | PubMed |
| 40316838 | Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40316838 | PubMed |
| 39564438 | The efficacy and application of tranexamic acid in emergency medicine: Emergency Medicine Association of Türkiye clinical policy- 2024. | Turk J Emerg Med | 2024 | https://conductscience.org/library/papers/39564438 | PubMed |
| 37228855 | The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. | Future Sci OA | 2023 | https://conductscience.org/library/papers/37228855 | PubMed |
| 37000863 | Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis. | PLoS One | 2023 | https://conductscience.org/library/papers/37000863 | PubMed |
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 35140671 | Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. | Front Neurol | 2021 | https://conductscience.org/library/papers/35140671 | PubMed |
| 35083272 | Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Front Surg | 2021 | https://conductscience.org/library/papers/35083272 | PubMed |
| 34677620 | Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34677620 | PubMed |
| 34315966 | Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34315966 | PubMed |
| 33851983 | Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. | JAMA Surg | 2021 | https://conductscience.org/library/papers/33851983 | PubMed |
| 33222913 | Subarachnoid hemorrhage rebleeding in the first 24 h is associated with external ventricular drain placement and higher grade on presentation: Cohort study. | J Clin Neurosci | 2020 | https://conductscience.org/library/papers/33222913 | PubMed |
| 32556832 | Tranexamic acid in Neurosurgery: a controversy indication-review. | Neurosurg Rev | 2021 | https://conductscience.org/library/papers/32556832 | PubMed |
| 23990381 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23990381 | PubMed |
| 21761274 | Rebleeding after aneurysmal subarachnoid hemorrhage. | Neurocrit Care | 2011 | https://conductscience.org/library/papers/21761274 | PubMed |
| 18386187 | Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. | Neurocrit Care | 2008 | https://conductscience.org/library/papers/18386187 | PubMed |
| 10400410 | Tranexamic acid: a review of its use in surgery and other indications. | Drugs | 1999 | https://conductscience.org/library/papers/10400410 | PubMed |
| 9854979 | Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. | J Neurol Neurosurg Psychiatry | 1998 | https://conductscience.org/library/papers/9854979 | PubMed |
| 7435291 | Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435291 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/354483
GET https://conductscience.org/api/papers/v1/354483/cited_by?page=2